Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection

J Clin Microbiol. 2011 Feb;49(2):725-7. doi: 10.1128/JCM.01028-10. Epub 2010 Dec 1.

Abstract

We compared two commercial PCR assays, the Prodesse ProGastro CD assay and the BD GeneOhm Cdiff assay, with a laboratory-developed Clostridium difficile toxin PCR assay with previously established performance characteristics. Results of all methods were in agreement for 333 (96%) of 346 stool specimens. No significant difference in performance among the assays was found (P values, >0.05).

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Bacterial Toxins / genetics
  • Bacteriological Techniques / methods*
  • Clostridioides difficile / genetics
  • Clostridioides difficile / isolation & purification*
  • Clostridium Infections / diagnosis*
  • Clostridium Infections / microbiology
  • Feces / microbiology
  • Humans
  • Molecular Diagnostic Techniques / methods*
  • Reagent Kits, Diagnostic
  • Sensitivity and Specificity

Substances

  • Bacterial Toxins
  • Reagent Kits, Diagnostic